QUINAZOLINE DERIVATIVES, METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF Russian patent published in 1998 - IPC

Abstract RU 2111209 C1

FIELD: organic chemistry. SUBSTANCE: quinazoline derivatives of the formula (I) $$$, its pharmaceutically acceptable salt or ester where $$$ - $$$-alkyl; $$$ - hydrogen, $$$-alkyl; $$$ - $$$-alkyl, $$$-alkenyl, $$$-alkynyl; Ar - phenylene that can has optionally one or two substituents taken from halogen, $$$-alkyl, $$$-alkoxy or pyridine-diyl. Quinazoline ring can has optionally a substituent at one of 5-, 7- and 8-positions taken from halogen and $$$-alkyl. Compound (I) $$$ is synthesized by interaction of acid of the formula (II) $$$ with compound of the formula (III) $$$ where $$$ have indicated values and $$$ - hydrogen or protective group; $$$ - protective group. Protective groups are removed by conventional method. Compound (I) $$$ is used as an active component in pharmaceutical composition exhibiting antitumor activity. EFFECT: improved method of synthesis. 12 cl, 2 tbl

Similar patents RU2111209C1

Title Year Author Number
QUINAZOLINE DERIVATIVES AND THEIR USE AS INHIBITORS OF VESSEL ENDOTHELIUM GROWTH FACTOR 1997
  • Tomas Ehndrju Peter
  • Dzhonstoun Krehjg
  • Ehnnekehn Loran Fransua Andre
RU2196137C2
QUINAZOLINE DERIVATIVES, METHOD OF PREPARATION THEREOF, PHARMACEUTICAL COMPOSITION, AND A METHOD FOR REACHING ANTIPROLIFERATIVE EFFECTS 1996
  • Kejt Khopkinson Gibson
RU2153495C2
DERIVATIVES OF QUINAZOLINE OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, A METHOD OF THEIR SYNTHESIS AND A PHARMACEUTICAL COMPOSITION BASED ON SAID 1993
  • Ehndrju Dzhon Barker
RU2127263C1
DERIVATIVES OF QUINAZOLINE, METHODS OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION COMPRISING THEREOF AND METHOD OF ACHIEVEMENT OF ANTI-ANGIOGENIC EFFECT AND/OR EFFECT OF DECREASE OF VASCULAR PENETRATION WITH THEIR USING 1996
  • Lomann Zhan-Zhak Marsel'
  • Ehnneken Loran Fransua Andre
  • Tomas Ehndrju Piter
RU2194701C2
DERIVATIVES OF QUATERNARY AMINOPYRIMIDINE AND PHARMACEUTICAL COMPOSITION 1990
  • Rodni Brajan Khargrivs[Gb]
  • Pol Vill'Jam Marshall[Gb]
  • Bernard Dzhozef Makloglin[Gb]
  • Stjuart Dennet Millz[Gb]
RU2108329C1
PHYSICAL FOAM OF (R)-3-METHOXY-4-1-METHYL-5- 2-METHYL- 4,4,4-TRIFLUOROBUTYLCARBAMOYL) INDOL-3-YLMETHYL-N-(2- METHYLPHENYL-SULPHONYL)BENZAMIDE, PHARMACEUTICAL COMPOSITION HAVING PROPERTIES OF LEUCOTRIENE ANTAGONIST 1992
  • Murrej Vatson Katbert[Gb]
RU2095348C1
DERIVATIVES OF NITROGENOUS YPERITE BOUND WITH AMINO ACIDS THAT ARE PRODRUG SUBSTRATES FOR CARBOXYPEPTIDASE ENZYME, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION AND BIOCOMPONENT SYSTEM FOR CYTOTOXIC DRUG DELIVERY 1993
  • Filip Dzh.Berk
  • Robert I.Dauehll
  • Ehntoni B.Mauger
  • Karolin Dzh.Springer
RU2129542C1
CARBOPENEM DERIVATIVES, THEIR PHARMACEUTICALLY ACCEPTABLE SALTS AND HYDROLYZED IN VIVO ESTERS (VARIANTS), METHOD OF SYNTHESIS (VARIANTS), PHARMACEUTICAL COMPOSITION SHOWING ANTIBACTERIAL ACTIVITY, DERIVATIVES OF PYRROLIDINE-4-YLTHIOL AND PROTECTED DERIVATIVES OF PYRROLIDINE-4-YLTHIOL 1993
  • Majkl Dzhon Betts
  • Garet Mors Dehvis
  • Majkl Lingard Svejn
RU2117659C1
NEW COMPOUNDS 2001
  • Ehriksson Tomas
  • Khenriksson Krister
RU2261245C2
NITROMETHANE DERIVATIVES AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF 1991
  • Stiven Pol Braun[Gb]
  • Ehntoni Loren Kuper[Gb]
  • Dzhetro Lorens Longridzh[Gb]
  • Dzheffri Dzhejms Morris[Gb]
  • Dzhon Preston[Gb]
RU2066680C1

RU 2 111 209 C1

Authors

Stiven Dzhon Pegg[Gb]

Dzhejms Majkl Vordlvert[Gb]

Dates

1998-05-20Published

1993-03-10Filed